Bremelanotide is designed to be self-administered subcutaneously with a disposable autoinjector at least 45 minutes before an anticipated sexual encounter, Krop said. Users don’t see the needle and it can be pushed against the abdomen or thigh, she said.
Zdroj: FDA Approves New Libido-Boosting Drug for Premenopausal Women
